All Adults on Aspirin
The purpose of this study is to determine the optimal dose of aspirin for secondary prevention in patients with ASCVD.
Principal Investigator: Peter McCullough, MD
Locations: Legacy Heart Center, Baylor Scott & White Heart and Vascular Hospital
Sponsor: Duke University
IRB Number: 016-067
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will not change your care
Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness (ADAPTABLE)
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.